Visioneering Technologies (ASX:VTI) Debt-to-EBITDA : 0.00 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Visioneering Technologies Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Visioneering Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.00 Mil. Visioneering Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.00 Mil. Visioneering Technologies's annualized EBITDA for the quarter that ended in Dec. 2023 was A$-4.84 Mil. Visioneering Technologies's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Visioneering Technologies's Debt-to-EBITDA or its related term are showing as below:

ASX:VTI' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.39 Med: -0.33 Max: -0.22
Current: -0.34

During the past 7 years, the highest Debt-to-EBITDA Ratio of Visioneering Technologies was -0.22. The lowest was -1.39. And the median was -0.33.

ASX:VTI's Debt-to-EBITDA is ranked worse than
100% of 429 companies
in the Medical Devices & Instruments industry
Industry Median: 1.21 vs ASX:VTI: -0.34

Visioneering Technologies Debt-to-EBITDA Historical Data

The historical data trend for Visioneering Technologies's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visioneering Technologies Debt-to-EBITDA Chart

Visioneering Technologies Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-EBITDA

Get a 7-Day Free Trial

-0.23

-0.44

-1.39

-0.22

Visioneering Technologies Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-EBITDA	Get a 7-Day Free Trial									-2.04	-0.46	-0.25	-0.33	-

Competitive Comparison of Visioneering Technologies's Debt-to-EBITDA

For the Medical Devices subindustry, Visioneering Technologies's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Visioneering Technologies's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Visioneering Technologies's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Visioneering Technologies's Debt-to-EBITDA falls into.

Visioneering Technologies Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Visioneering Technologies's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0	+	0)	/	-5.026
	=	0.00

Visioneering Technologies's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0	+	0)	/	-4.844
	=	0.00

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.

Visioneering Technologies (ASX:VTI) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Visioneering Technologies Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Visioneering Technologies's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Visioneering Technologies (ASX:VTI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Visioneering Technologies Inc (ASX:VTI) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

10745 Westside Way, Suite 200, Alpharetta, GA, USA, 30009

Website

http://www.vtivision.com

Visioneering Technologies Inc is a medical device company. It designs, manufactures, sales and distributes its NaturalVue daily disposable multifocal contact lenses for adults with Presbyopia and children with Myopia. The company offers NaturalVue MF contact lenses. Its Multifocal contact lens provides Presbyopia patients with near, intermediate, and distance vision and which is much easier for eye care professionals to fit their patients.